Pyridostigmine Bromide
NDC 58657-811, PYRIDOSTIGMINE BROMIDE, tablet, from Method Pharmaceuticals, LLC.
- Product NDC
- 58657-811
- Status
- Listed
- Labeler
- Method Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211181
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58657-811 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE60 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58657-811-01 | 58657081101 | 100 TABLET in 1 BOTTLE (58657-811-01) |
| 58657-811-30 | 58657081130 | 30 TABLET in 1 BOTTLE (58657-811-30) |
| 58657-811-90 | 58657081190 | 90 TABLET in 1 BOTTLE (58657-811-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1aa7a886-c726-cc91-e063-6294a90a1af1
Use it
Look up 58657-811 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58657-811 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58657-811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.